MARKET

LGND

LGND

Ligand Pharma
NASDAQ
80.40
-0.94
-1.16%
Opening 10:36 06/14 EDT
OPEN
81.00
PREV CLOSE
81.34
HIGH
81.23
LOW
80.24
VOLUME
8.22K
TURNOVER
0
52 WEEK HIGH
94.57
52 WEEK LOW
49.24
MARKET CAP
1.44B
P/E (TTM)
15.36
1D
5D
1M
3M
1Y
5Y
Compelling Reasons to Hold on to HCA Healthcare (HCA) Stock
NASDAQ · 20h ago
SLYG's Holdings Imply 13% Gain Potential
NASDAQ · 1d ago
Weekly Report: what happened at LGND last week (0603-0607)?
Weekly Report · 4d ago
New Strong Buy Stocks for June 6th
NASDAQ · 06/06 10:55
Ligand Pharmaceuticals Down Nearly 9%, on Pace for Largest Percent Decrease Since January 2023 -- Data Talk
Dow Jones · 06/04 17:24
Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?
NASDAQ · 06/04 13:55
Craig-Hallum Reaffirms Their Buy Rating on Ligand Pharma (LGND)
TipRanks · 06/04 13:15
Ligand Pharma: Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Press release · 06/03 20:45
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several United States Food and Drug Administration (FDA)-approved products, including Gilead's Veklury, Amgen's Kyprolis, Baxter International's Nexterone, Melinta Therapeutics' Baxdela and Sage Therapeutics' Zulresso. Its technologies also include HepDirect, LTP and BEPro Technology Platform, SUREtechnology Platform (owned by Selexis), and Pelican Expression Technology. It has established multiple alliances, licenses and other business relationships with various pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences and Baxter International.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.